Renal angina: concept and development of pretest probability assessment in acute kidney injury

被引:0
作者
Lakhmir S Chawla
Stuart L Goldstein
John A Kellum
Claudio Ronco
机构
[1] Veterans Affairs Medical Center,Department of Medicine, Division of Intensive Care Medicine and Division of Nephrology
[2] George Washington University Medical Center,Department of Anesthesiology and Critical Care Medicine
[3] Cincinnati Children’s Hospital Medical Center,Center for Acute Care Nephrology
[4] University of Pittsburgh School of Medicine,Department of Critical Care Medicine, Center for Critical Care Nephrology, The CRISMA (Clinical Research, Investigation, and Systems Modeling of Acute Illness) Center
[5] San Bortolo Hospital,Department of Nephrology, Dialysis & Transplantation, International Renal Research Institute
来源
Critical Care | / 19卷
关键词
Acute Coronary Syndrome; Angina Pectoris; Negative Predictive Value; Acute Kidney Injury; Pretest Probability;
D O I
暂无
中图分类号
学科分类号
摘要
The context of a diagnostic test is a critical component for the interpretation of its result. This context defines the pretest probability of the diagnosis and forms the basis for the interpretation and value of adding the diagnostic test. In the field of acute kidney injury, a multitude of early diagnostic biomarkers have been developed, but utilization in the appropriate context is less well understood and has not been codified until recently. In order to better operationalize the context and pretest probability assessment for acute kidney injury diagnosis, the renal angina concept was proposed in 2010 for use in both children and adults. Renal angina has been assessed in approximately 1,000 subjects. However, renal angina as a concept is still unfamiliar to most clinicians and the rationale for introducing the term is not obvious. We therefore review the concept and development of renal angina, and the currently available data validating it. We discuss the various arguments for and against this construct. Future research testing the performance of renal angina with acute kidney injury biomarkers is warranted.
引用
收藏
相关论文
共 122 条
[1]  
Ebell MH(2000)A systematic review of troponin T and I values as a prognostic tool for patients with chest pain J Fam Pract 49 746-753
[2]  
White LL(2008)Prognostic implications of normal (<0.10 ng/ml) and borderline (0.10 to 1.49 ng/ml) troponin elevation levels in critically ill patients without acute coronary syndrome Am J Cardiol 102 509-512
[3]  
Weismantel D(2010)Etiology of troponin elevation in critically ill patients J Crit Care 25 322-328
[4]  
Stein R(2013)High-sensitivity cardiac troponin T compared with standard troponin T testing on emergency department admission: how much does it add in everyday clinical practice? J Am Heart Assoc 2 e000204-766
[5]  
Gupta B(2012)Acute kidney injury Lancet 380 756-820
[6]  
Agarwal S(2011)Biological markers of acute kidney injury J Am Soc Nephrol 22 810-219
[7]  
Golub J(2007)Diagnosis of acute kidney injury: from classic parameters to new biomarkers Contrib Nephrol 156 213-212
[8]  
Bhutani D(2007)Emerging biomarkers of acute kidney injury Contrib Nephrol 156 203-436
[9]  
Rosman A(2007)Assessing the clinical utility of biomarkers in medicine Biomark Med 1 419-949
[10]  
Lim W(2013)Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury Crit Care 17 R25-667